Drugs / 68-Ga-DOTANOC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01747096 | Nov 2012 → May 2016 | digestive system neuroendocrine neoplasm | Nantes University Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 68-Ga-DOTANOC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01747096 ↗ |
| Modality | Diagnostic / imaging agent | “Evaluation of the diagnostic performance of PET / CT with 68Ga-DOTANOC” NCT01747096 ↗ |